Approval · Notice of Compliance 2598 · 2001
URSO TABLETS: Notice of Compliance 2598
Issued January 30, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2598
- Date
- January 30, 2001
- Company
- Axcan Pharma Inc.Mont St-Hilaire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Removal of indication for gallstone dissolution
- Therapeutic class
- Cholestatic liver diseases
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| URSO TABLETS | Not yet assigned | — |
Medicinal ingredients
- URSODIOL 250 MG per TAB